Provided by Tiger Trade Technology Pte. Ltd.

Celldex Therapeutics

40.57
+0.19000.47%
Post-market: 40.570.00000.00%16:20 EDT
Volume:416.89K
Turnover:16.90M
Market Cap:3.18B
PE:-9.35
High:40.98
Open:40.16
Low:39.53
Close:40.38
52wk High:45.14
52wk Low:21.34
Shares:78.49M
Float Shares:73.02M
Volume Ratio:0.43
T/O Rate:0.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3401
EPS(LYR):-3.9000
ROE:-43.88%
ROA:-27.62%
PB:4.46
PE(LYR):-10.40

Loading ...

U.S. RESEARCH ROUNDUP- Datadog, Eli Lilly, Oracle

Reuters
·
Jun 10

A Look At Celldex Therapeutics (CLDX) Valuation After Recent Share Price Pullback And Mixed P/B And DCF Signals

Simply Wall St.
·
Jun 10

Celldex publishes investor presentation highlighting barzolvolimab late-stage urticaria trials and broader mast cell disease pipeline

Reuters
·
May 28

Celldex Therapeutics Is Maintained at Overweight by Wells Fargo

Dow Jones
·
May 13

U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic

Reuters
·
May 13

The Bull Case For Celldex Therapeutics (CLDX) Could Change Following Q1 Loss And Barzolvolimab Milestones

Simply Wall St.
·
May 12

Celldex Therapeutics Is Maintained at Overweight by Barclays

Dow Jones
·
May 08

Celldex Therapeutics Inc expected to post a loss of $1.15 a share - Earnings Preview

Reuters
·
May 08

Celldex price target raised to $48 from $45 at Barclays

TIPRANKS
·
May 08

Analysts Are Bullish on These Healthcare Stocks: Tectonic Therapeutic (TECX), Celldex (CLDX)

TIPRANKS
·
May 08

Celldex Therapeutics Q1 EPS $(1.18) Beats $(1.20) Estimate, Sales $15.000K Miss $972.222K Estimate

Benzinga Earnings
·
May 08

Celldex Q1 net loss widens to $78.7 million; R&D expenses rise to $73 million

Reuters
·
May 08

Celldex Therapeutics Q1 Operating Income USD -84.435 Million

THOMSON REUTERS
·
May 08

Celldex Reports First Quarter Financial Results and Provides Corporate Update

GlobeNewswire
·
May 08

Assessing Celldex Therapeutics (CLDX) Valuation After Strong Recent Share Price Gains

Simply Wall St.
·
Apr 22

BUZZ-U.S. STOCKS ON THE MOVE-Adobe, Agios, QXO

Reuters
·
Apr 20

A Top Wall Street Analyst ‘Can’t Ignore’ Celldex Stock (CLDX)

TIPRANKS
·
Apr 20

Celldex Therapeutics Shares up 0.8% After Barclays Double Upgrades to Overweight

THOMSON REUTERS
·
Apr 20

Celldex Therapeutics Raised to Overweight From Underweight by Barclays

Dow Jones
·
Apr 20

BUZZ-U.S. STOCKS ON THE MOVE-TopBuild, MDA Space, Biogen

Reuters
·
Apr 20